European Commission logo
español español
CORDIS - Resultados de investigaciones de la UE
CORDIS

Pharmaceutical Open Innovation Test Bed for Enabling Nano-pharmaceutical Innovative Products

Resultado final

Phoenix Webpage

Phoenix webpage for project and OITB visibility and transparency

Open Call Document

The democases will be chosen after a competitive open call that will be launched by the PhoenixOITB and will be announced and communicated through Phoenix website

LinkedIn, Twitter, ResearchGate accounts created and active

BNN manages social media accounts for increasing visibility disseminating the progress and results

Online Draft and Final Phoenix Service Portfolio including prices and conditions

List of high standard of service to stakeholders as an integrated association of complementary service providers across Europe Draft version will be s on M18 amd teh final version on 48

Foundation of the Phoenix-OITB

PhoenixOITB will be established officially and legally as a nonprofit association

Publicaciones

High-Throughput Method for the Simultaneous Determination of Doxorubicin Metabolites in Rat Urine after Treatment with Different Drug Nanoformulations

Autores: Lara Zorić; Nikša Drinković; Vedran Micek; Leo Frkanec; Akif Emre Türeli; Nazende Günday-Türeli; Ivana Vinković Vrček; Ruža Frkanec
Publicado en: Molecules, Edición 2, 2022, ISSN 1420-3049
Editor: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/molecules27041177

Imaging mass spectrometry differentiates the effects of doxorubicin formulations on non-targeted tissues

Autores: Željko Debeljak, Ivana Vinković Vrček, Nikša Drinković, Vedran Micek, Emerik Galić, Dunja Gorup, Marija Ćurlin, Dario Mandić, Ana Bandjak, Barbara Pem, Nikolina Kalčec, Krunoslav Ilić, Ivan Pavičić, Suzana Mimica, Nazende Günday-Türeli and Emre Türeli
Publicado en: Analyst, 2022, ISSN 1364-5528
Editor: Royal Society of Chemistry
DOI: 10.1039/d2an00355d

Hierarchical Quatsome-RGD Nanoarchitectonic Surfaces for Enhanced Integrin-Mediated Cell Adhesion

Autores: Marc Martínez-Miguel; Miquel Castellote-Borrell; Mariana Köber; Adriana R. Kyvik; Judit Tomsen-Melero; Guillem Vargas-Nadal; Jose Muñoz; Daniel Pulido; Edgar Cristóbal-Lecina; Solène Passemard; Miriam Royo; Marta Mas-Torrent; Jaume Veciana; Marina I. Giannotti; Judith Guasch; Nora Ventosa; Imma Ratera
Publicado en: ACS Applied Materials and Interfaces, Edición 14, 42, 2022, ISSN 1944-8244
Editor: American Chemical Society
DOI: 10.1021/acsami.2c10497

Liposomal formulations for treating lysosomal storage disorders

Autores: Judit Tomsen-Melero; Josep Merlo-Mas; Aida Carreño; Santi Sala; Alba Córdoba; Jaume Veciana; Elisabet González-Mira; Nora Ventosa
Publicado en: Advanced Drug Delivery Reviews, Edición vol 190, 2022, ISSN 1872-8294
Editor: Elsevier
DOI: 10.1016/j.addr.2022.114531

DELOS Nanovesicles-Based Hydrogels: An Advanced Formulation for Topical Use

Autores: Lídia Ballell-Hosa; Elisabet González-Mira; Hector Santana; Judit Morla-Folch; Marc Moreno-Masip; Yaima Martínez-Prieto; Albert Revuelta; Primiano Pio Di Mauro; Jaume Veciana; Santi Sala; Lidia Ferrer-Tasies; Nora Ventosa
Publicado en: Pharmaceutics; Volume 14; Edición 1; Pages: 199, Edición 1, 2022, Página(s) MDPI, ISSN 1999-4923
Editor: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/pharmaceutics14010199

Stable nanovesicles formed by intrinsically planar bilayers

Autores: Mariana Köber, Sílvia Illa-Tuset, Lidia Ferrer-Tasies, Evelyn Moreno-Calvo, Witold I. Tatkiewicz, Natascia Grimaldi, David Piña, Alejandro Pérez Pérez, Vega Lloveras, José Vidal-Gancedo, Donatella Bulone, Imma Ratera, Jan Skov Pedersen, Dganit Danino, Jaume Veciana, Jordi Faraudo, Nora Ventosa
Publicado en: Journal of Colloid and Interface Science, Edición Volume 631, Part A, 2023, Página(s) Pages 202-211,, ISSN 0021-9797
Editor: Academic Press
DOI: 10.1016/j.jcis.2022.10.104

Multiscale imaging of the immune cell therapy biodistribution

Autores: de Kruijf, Robbin; Srinivas, Mangala; Simon, James
Publicado en: Edición 1, 2023
Editor: Advanced Therapies
DOI: 10.5281/zenodo.10658241

PHOENIX-OITB – A single entry point to develop and upgrade innovative nanopharmaceuticals

Autores: Scheper, Johanna; Cordoba, Alba; Padrós, Ariadna; Ventosa, Nora; De la Fuente, Jesus M.; Vinković Vrček, Ivana; Bauer, Hannes; Srinivas, Mangala; Fleischer, Sabine; Holzer, Robert; Serchi, Tommaso; Günday-Türeli, Nazende
Publicado en: Edición 2, 2023
Editor: BioNanoMed 2023
DOI: 10.5281/zenodo.7851928

Buscando datos de OpenAIRE...

Se ha producido un error en la búsqueda de datos de OpenAIRE

No hay resultados disponibles